Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
16th Mar 2021 7:00 am RNS US supply agreement for additional AZD7442 doses
9th Mar 2021 3:00 pm RNS Director/PDMR Shareholding
4th Mar 2021 3:00 pm RNS Designation of EU home member state
3rd Mar 2021 7:00 am RNS US court decision favours Symbicort patents
2nd Mar 2021 7:00 am RNS Further update on roxadustat US regulatory review
1st Mar 2021 3:00 pm RNS Total Voting Rights
22nd Feb 2021 7:00 am RNS Voluntary withdrawal Imfinzi US bladder indication
17th Feb 2021 7:00 am RNS Lynparza: IDMC recommend early analysis of OlympiA
16th Feb 2021 11:15 am RNS Filing of Form 20-F with SEC
15th Feb 2021 3:00 pm RNS Director/PDMR Shareholding
15th Feb 2021 11:00 am RNS Annual Financial Report
11th Feb 2021 7:01 am RNS AstraZeneca Non-Executive Board changes
11th Feb 2021 7:00 am RNS AZN: full-year 2020 results
10th Feb 2021 7:00 am RNS Divestment of Crestor in Europe completed
5th Feb 2021 7:00 am RNS Update on KESTREL Phase III trial for Imfinzi
4th Feb 2021 7:00 am RNS Forxiga approved in China for heart failure
1st Feb 2021 3:00 pm RNS Total Voting Rights
1st Feb 2021 12:15 pm RNS AstraZeneca agrees to divest Viela shareholding
1st Feb 2021 7:00 am RNS COVID-19 vaccine authorised for use by the EU
29th Jan 2021 3:16 pm RNS COVID-19 vaccine receives positive opinion in EU
26th Jan 2021 3:00 pm RNS Block listing application
26th Jan 2021 7:00 am RNS Symbicort approved in China for mild asthma
25th Jan 2021 7:05 am RNS Calquence approved in Japan for CLL
25th Jan 2021 7:00 am RNS Calquence met primary endpoint against ibrutinib
20th Jan 2021 7:00 am RNS Enhertu approved in the EU for breast cancer
18th Jan 2021 7:00 am RNS Enhertu approved in the US for gastric cancer
15th Jan 2021 7:00 am RNS Imfinzi new dosing approved in EU
6th Jan 2021 7:00 am RNS Farxiga granted US Priority Review for CKD
4th Jan 2021 3:00 pm RNS Total Voting Rights
4th Jan 2021 7:00 am RNS Atacand divestment in over 70 countries completed
30th Dec 2020 7:00 am RNS AstraZeneca’s COVID-19 vaccine authorised in UK
29th Dec 2020 7:00 am RNS Lynparza approved in Japan for three cancers
21st Dec 2020 7:05 am RNS Tagrisso approved in the US for early lung cancer
21st Dec 2020 7:00 am RNS Update on US regulatory review of roxadustat
17th Dec 2020 4:00 pm RNS Director/PDMR Shareholding
16th Dec 2020 6:15 pm RNS Director/PDMR Shareholding
15th Dec 2020 7:00 am RNS Imfinzi new dose receives positive EU CHMP opinion
14th Dec 2020 7:05 am RNS Trastuzumab deruxtecan positive CHMP
14th Dec 2020 7:00 am RNS Trixeo Aerosphere approved in the EU for COPD
14th Dec 2020 7:00 am RNS AstraZeneca to acquire Alexion Pharmaceuticals Inc
FTSE 100 Latest
Value9,068.58
Change-64.23